Search results
Author(s):
Heng Shee Kim
,
Hou Tee Lu
Added:
1 year ago
Author(s):
Natnicha Pongbangli
,
Thanaporn Anuchai
,
Sasivimon Jai-aue
,
et al
Added:
4 weeks ago
Author(s):
Rohullah Sultani
,
Jasmine Chan
,
Timothy Abrahams
,
et al
Added:
1 week ago
Author(s):
Colin Yeo
,
Xuan Han Koh
,
Weien Chow
,
et al
Added:
9 months ago
Author(s):
Kapil Rajendran
,
Abdul Salam
,
Jayaram Vasu
Added:
1 year ago
Author(s):
Billy Joseph David
,
Reynald Evan R Tugade
,
Ferdinand Jr Gerodias
Added:
2 years ago
Author(s):
Jonas Brinck
Added:
5 months ago
ESC Congress 2025 - Cascade screening proves to be an effective tool to identify more patients with elevated LP(a) levels.Dr Jonas Brinck (Karolinska Institute, SE) joins us to discuss findings from the LipoaScreen study, evaluating cascade screening for elevated lipoprotein(a) in relatives of patients with atherosclerotic coronary artery disease.This prospective study examined whether elevated…
View more
Author(s):
Alexander Fanaroff
Added:
1 year ago
ACC.24 — Dr Alexander Fanaroff (Penn Medicine, US) joins us onsite at ACC.24 to discuss the findings from the BE ACTIVE study, which investigated behavioural economic approaches to increasing physical activity (PA) in patients with an elevated risk of cardiovascular disease (NCT03911141).This randomized, controlled trial enrolled 1062 patients with a 10-year atherosclerotic cardiovascular risk…
View more
Author(s):
Michelle O'Donoghue
Added:
2 years ago
ESC 23 — Dr Michelle O'Donoghue (Brigham and Women's Hospital, US) outlines a trial update from OCEAN(a)-Dose Extension trial (NCT05581303) in this succinct interview.
OCEAN(a)-DOSE (Amgen) was a dose-finding study aiming to evaluate a siRNA, olpasiran, and its effect on risk for coronary heart disease death, myocardial infarction or urgent coronary revascularization when administered…
View more